Curated Video
Diane Rehm On The 'Right-To-Die' Movement And Her New Book
Rehm's new book captures both sides of the aid in dying debate, including interviews with physicians, terminally ill patients and ethicists.
Bloomberg
Roche CEO: We’ll See Continued Pressure on Drug Prices
Jan.09 -- Roche Pharma CEO Daniel O'Day discusses drug pricing and medical care policy changes under the Trump administration. He speaks on “Bloomberg Markets.â€
Bloomberg
We Are Positive on Momentum in U.S. Business, Says Novo Nordisk CEO
Dec.10 -- Lars Fruergaard Jorgensen, chief executive officer at Novo Nordisk A/S, discusses the competitive environment for diabetes drugs, growth in the U.S. and innovation in the hemophilia space. He speaks on “Bloomberg Markets:...
Bloomberg
Economist Stiglitz Sees `Major Structural Changes' in Demand
May.18 -- Joseph Stiglitz, professor at Columbia University, anticipates "major structural changes in demand" as the economic fallout from the coronavirus pandemic deepens. He speaks on "Bloomberg Daybreak: Americas."
Press Association
Jeremy Corbyn claims he has evidence the Tories will put the 'NHS up for sale'
Labour has accused the Conservatives of negotiating a secret trade deal with the US to open up the NHS to American pharmaceutical companies. Jeremy Corbyn said they had obtained uncensored Government documents showing talks were at a...
Sky News
Cancer Drugs Face Axe In NHS Cost-Cutting Move
VOICED: Cancer Drugs Face Axe in NHS Cost Cutting Move Showing Interior shots Bowel cancer patient Ben Ashworth at home with family, cancer research lab, Ben Ashworth jogging in park, Interviews with Ben Ashworth, Patient, Dr Dan...
Bloomberg
Pfizer CEO Urges Biden to Form Bipartisan Coalition on Drug Costs
Jun.18 -- Pfizer Chairman and CEO Albert Bourla says the out-of-pocket drug costs now paid by U.S. patients “is something that needs to be fixed" and suggests President Joe Biden form a bipartisan coalition in Washington to address the...
Press Association
EU: Serious headway needed over Northern Ireland protocol
“Serious headway” needs to be made in negotiations over the Northern Ireland Protocol in the next week, the EU has said.
Bloomberg
Bristol Myers CEO on second quarter, infrastructure
Jul.28 -- Dr. Giovanni Caforio, Bristol Myers Squibb CEO, discusses second quarter performance, potential tax impacts of a U.S. infrastructure plan and what type of deals the company plans to pursue.
AFP News Agency
CLEAN : Gambian health authorities recall cough syrups linked with deaths of 66 children
Gambian Red Cross officials go door to door, collecting cough syrups that the country's Health Ministry has linked to an outbreak of kidney failure that has killed 66 children (Footage by AFPTV via Getty Images)
Curated Video
Reax to law ending manufacture of low cost drug copies
FILE - New Delhi
1. Various of Parliament exterior
2. Various of members of Parliament entering
3. Various of anti-retroviral drugs
FILE - Various
4. Various of HIV/AIDS patients in Africa and India
New Delhi - 23 March, 2005
5. Office...
Bloomberg
Novartis CEO on Earnings, New Drug Approvals, Drug Prices, Generics
Jan.30 -- Vasant Narasimhan, chief executive officer at Novartis, discusses 4Q earnings, his plan for new drug approvals, how his business could be impacted by Brexit, pricing pressure in the U.S., the generics business and their Roche...
Press Association
Effects of Covid-19 will be 'catastrophic' in developing countries, says healthcare app creator as he predicts millions of deaths
The CEO of Reach52, Ed Booty, predicts a further millions of Covid-19 deaths in developing countries, and for eradication of the disease to take years due to poor access to healthcare. The organisation provides apps used by frontline...
Bloomberg
Eli Lilly CEO on 3Q Results, Drug-Pricing Reforms
Oct.23 -- Dave Ricks, chief executive officer at Eli Lilly, discusses third-quarter results and competing drug-pricing reform plans in the U.S. House and Senate. He speaks with Bloomberg’s Alix Steel on "Bloomberg Daybreak: Americas."
Bloomberg
Galapagos Shares Surge on $5.1 Billion Gilead Investment
Jul.15 -- Andre Hoekema, chief business officer at Galapagos, discusses the $5.1 billion investment into the company by Gilead Sciences Inc. He speaks with Bloomberg's Nejra Cehic on "Bloomberg Surveillance."
Bloomberg
Moderna Sharing Less Data Since IPO, CEO Says
May.13 -- Moderna Inc. Chief Executive Officer Stephane Bancel discusses the biotech firm's recent initial public offering and pharmaceuticals development path on "Bloomberg Technology."
Bloomberg
Bristol-Meyers Squibb CEO on Covid-19, Political Contributions
Jan.12 -- Bristol-Meyers Squibb Chief Executive Officer Giovanni Cafario discusses the overall impact of Covid-19 on the healthcare industry, remaining focused on innovation, and pausing contributions to political candidates. He speaks...
Sky News
Vaccine Science Briefing
CLEAN: Interior shots of Chief Executive of the Medicines and Healthcare products Regulatory Agency Dr June Raine announcing the approval of use of the Pfizer Biontech Covid vaccine on 2nd December 2020 in London, United Kingdom.
Press Association
Mary Lou McDonald speaks on Brexit medicines disruption
Sinn Fein leader Mary Lou McDonald and UUP leader Doug Beattie claim the EU has pledged to legislate to address concerns that the supply to medicines into Northern Ireland will be disrupted by the NI Protocol.
Bloomberg
Roche CEO Sees Strong Demand for Covid Antibody Cocktail
Severin Schwan, chief executive officer at Roche Holding AG, discusses third-quarter earnings, the demand for Covid-19 tests and the company’s M&A strategy. Roche’s third-quarter revenue climbed 8.7% to $17.3 billion. He speaks on...
Bloomberg
Novartis Starts Review of Generic-Drug Unit
Novartis AG may spin off or sell its Sandoz generic-drug unit after it consistently failed to meet expectations, with U.S. sales plummeting this year amid the Covid-19 pandemic. Chief Executive Officer Vas Narasimhan says now is the...